LRRK2 variant spectrum and association study in a multi-ethnic cohort of Malaysian Parkinson’s disease patients
This study presents the most comprehensive catalog of LRRK2 variants in a multi-ethnic Malaysian Parkinson's disease cohort, identifying 77 heterozygous non-synonymous variants and confirming the significant association of the p.G2385R risk allele with increased disease susceptibility in the Chinese subgroup.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Parkinson's disease is a condition that slowly affects how the brain controls movement, often causing tremors, stiffness, and difficulty walking. While the exact cause remains a mystery for most patients, scientists have long known that genetics plays a significant role in some cases. One specific gene, called LRRK2, acts like a switchboard in the cell, sending signals that help keep brain cells healthy. When this gene has certain errors, or variants, it can malfunction, increasing the risk of developing the disease. These genetic errors are not the same for everyone; they vary widely depending on a person's ancestry. For decades, genetic research has focused heavily on populations in Europe and East Asia, leaving large gaps in our understanding of how these genes behave in other parts of the world, particularly in Southeast Asia.
A team of researchers from Malaysia and international partners set out to fill this gap by studying the genetic landscape of Parkinson's disease in their own diverse population. They gathered a large group of people, including over two thousand patients diagnosed with Parkinson's and more than a thousand healthy individuals who served as a comparison group. This group was not uniform; it included people of Chinese, Malay, Indian, and Indigenous heritage, reflecting the rich ethnic tapestry of Malaysia. By examining the DNA of these participants, the scientists aimed to create a complete map of the LRRK2 gene variants found in this region, looking for known disease-causing errors, common risk factors, and entirely new genetic changes that had never been seen before.
The researchers found that the genetic picture in Malaysia is complex and distinct. They identified seventy-seven different variations in the LRRK2 gene across their study group. Among these, they confirmed the presence of four known disease-causing variants, which are rare but serious errors that can directly lead to Parkinson's. They also found three common variations that act as risk factors, making it more likely for a person to develop the disease, though they do not guarantee it. Perhaps most significantly, the team discovered five brand-new genetic variants that had never been reported in scientific literature before. These new findings, along with dozens of other changes whose effects are still unclear, provide a crucial catalog of genetic diversity that was previously missing from global databases.
When the team looked closely at who carried which variants, a clear pattern emerged based on ancestry. One specific risk variant, known as p.G2385R, was found to be significantly more common in patients of Chinese descent compared to healthy controls. The data showed that carrying this variant increased the risk of developing Parkinson's by more than three times in this group. Another variant, p.R1628P, was found across Chinese, Malay, and Indigenous groups, but the statistical link to the disease was not as strong or consistent as the first one. Interestingly, the researchers also looked for a specific combination of genetic changes that had been found to be protective in other Asian populations, acting as a shield against the disease. While they found this protective pattern, the evidence in this specific Malaysian cohort was not strong enough to confirm it as a major protective factor after rigorous statistical testing.
The study also examined how these genetic factors influenced the timing of the disease. The researchers compared the age at which patients were diagnosed, looking to see if carrying certain genetic errors made the disease appear earlier in life. They found that patients who carried two different risk variants at the same time tended to be diagnosed slightly earlier, on average around fifty-four years old, compared to those without these specific genetic markers, who were diagnosed around fifty-nine. However, this difference was not large enough to be considered a definitive rule, suggesting that while genetics plays a part, other factors also influence when the disease strikes.
Beyond the common variants, the researchers paid close attention to the rare and newly discovered changes. They identified several "high-interest" variants that showed signs of potentially being harmful, such as one that appeared to increase the activity of the protein in a way that could damage cells. They also found five completely novel variants that were unique to this study. Because these new changes were so rare and had not been seen in other large databases, the scientists could not immediately say if they caused the disease. They noted that these variants appeared in patients with a family history of Parkinson's, which hints that they might be important, but further testing is needed to confirm their role.
This work represents the most comprehensive look at the LRRK2 gene in a multi-ethnic Southeast Asian population to date. By including groups like the Malay and Indigenous peoples, who have been underrepresented in global genetic studies, the researchers have provided a much clearer picture of how Parkinson's disease genetics work in this region. Their findings confirm that while some genetic risks are shared across populations, others are specific to certain ancestral groups. This detailed map of genetic variation is not just a list of data points; it is a vital resource that will help scientists develop better tests and more targeted treatments for Parkinson's disease in the future, ensuring that medical advances benefit people of all backgrounds.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.